|
EXOSC4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.676350E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.110100E-02 |
| Normal-vs-Stage2 |
3.524900E-03 |
| Normal-vs-Stage3 |
6.492800E-01 |
| Normal-vs-Stage4 |
8.024200E-01 |
| Stage1-vs-Stage2 |
1.901590E-01 |
| Stage1-vs-Stage3 |
4.865600E-01 |
| Stage1-vs-Stage4 |
3.186400E-01 |
| Stage2-vs-Stage3 |
5.813900E-02 |
| Stage2-vs-Stage4 |
1.449990E-01 |
| Stage3-vs-Stage4 |
5.966600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.930450E-02 |
| Normal-vs-AfricanAmerican |
1.246810E-01 |
| Normal-vs-Asian |
9.362400E-01 |
| Caucasian-vs-AfricanAmerican |
9.868600E-01 |
| Caucasian-vs-Asian |
4.324400E-01 |
| AfricanAmerican-vs-Asian |
5.386800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.137100E-03 |
| Normal-vs-Female |
3.786800E-01 |
| Male-vs-Female |
3.688400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.361000E-01 |
| Normal-vs-Extreme_Weight |
3.012200E-01 |
| Normal-vs-Obese |
7.970200E-02 |
| Normal-vs-Extreme_Obese |
1.697640E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.295200E-01 |
| Normal_Weight-vs-Obese |
3.962600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.361200E-01 |
| Extreme_Weight-vs-Obese |
3.168000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.651800E-01 |
| Obese-vs-Extreme_Obese |
9.563400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.250000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.038600E-03 |
| Normal-vs-Age(61-80Yrs) |
1.585240E-01 |
| Normal-vs-Age(81-100Yrs) |
6.718400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.457600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.838600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.744500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.092230E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.044400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.120200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.142210E-02 |
| Normal-VS-Type2 PRCC |
6.223500E-02 |
| Normal-VS-KIRP CIMP |
1.663160E-01 |
| Normal-VS-Unclassified PRCC |
1.254360E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.931800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.567000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.319200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.681000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.520000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.974000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.124800E-01 |
| Normal-vs-N1 |
4.523400E-01 |
| Normal-vs-N2 |
6.915000E-01 |
| N0-vs-N1 |
9.594000E-01 |
| N0-vs-N2 |
5.716600E-01 |
| N1-vs-N2 |
5.772400E-01 |
|
|
